(DYN) Dyne Therapeutics - Performance -56% in 12m
Compare DYN with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-42.45%
#59 in Group
Rel. Strength
9.41%
#7208 in Universe
Total Return 12m
-56.03%
#118 in Group
Total Return 5y
-52.26%
#62 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG 0.19
61th Percentile in Group
FCF Yield -40.41%
6th Percentile in Group
12m Total Return: DYN (-56%) vs XBI (-14%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
UTHR NASDAQ United Therapeutics |
2.95% | 13.3% | 161% | 12.1 | 11 | 1.43 | 74.6% | 16.1% |
HLN NYSE Haleon |
12.6% | 32.2% | 49.3% | 24.4 | 20.2 | 1.79 | 69.1% | 13.6% |
AMGN NASDAQ Amgen |
-8.67% | -12.4% | 27.7% | 25.5 | 13.5 | 0.95 | 0.60% | 41% |
LONN SW Lonza |
15.8% | 12% | 33.5% | 67.1 | 35.1 | 1.28 | 2.20% | -12.5% |
BIM PA Biomerieux |
4.68% | 18.2% | -1.63% | 32.5 | 25.2 | 1.52 | -38.5% | -25.1% |
KMDA NASDAQ Kamada |
14.1% | 27.3% | -5.64% | 26.6 | 23.9 | 0.96 | 32.5% | 3.93% |
NBIX NASDAQ Neurocrine Biosciences |
21.4% | -17.2% | 1.88% | 32.3 | 21.6 | 0.27 | 68.0% | 31.9% |
ERF PA Eurofins Scientific SE |
22.4% | 0.59% | 8.05% | 26.6 | 13.6 | 0.56 | -66.6% | -17.1% |
Performance Comparison: DYN vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for DYN
Total Return (including Dividends) | DYN | XBI | S&P 500 |
---|---|---|---|
1 Month | 51.13% | 2.02% | 2.87% |
3 Months | -21.20% | -15.44% | -6.42% |
12 Months | -56.03% | -14.02% | 9.87% |
5 Years | -52.26% | -26.47% | 107.51% |
Trend Score (consistency of price movement) | DYN | XBI | S&P 500 |
1 Month | 77.7% | 57% | 89.4% |
3 Months | -77.1% | -82.3% | -72% |
12 Months | -83.9% | -53.1% | 49.3% |
5 Years | 10.7% | -53.9% | 84.1% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #44 | 48.1% | 46.9% |
3 Month | #95 | -6.82% | -15.8% |
12 Month | #118 | -48.9% | -60.0% |
5 Years | #54 | -28.4% | -73.5% |
FAQs
Does DYN Dyne Therapeutics outperforms the market?
No,
over the last 12 months DYN made -56.03%, while its related Sector, the SPDR S&P Biotech (XBI) made -14.02%.
Over the last 3 months DYN made -21.20%, while XBI made -15.44%.
Over the last 3 months DYN made -21.20%, while XBI made -15.44%.
Performance Comparison DYN vs Indeces and Sectors
DYN vs. Indices DYN is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | -3.36% | 48.3% | -54.3% | -65.9% |
US NASDAQ 100 | QQQ | -3.61% | 46.4% | -54.7% | -67.4% |
US Dow Jones Industrial 30 | DIA | -3.64% | 49.5% | -53.3% | -62.4% |
German DAX 40 | DAX | -5.48% | 31.9% | -79.9% | -81.1% |
Shanghai Shenzhen CSI 300 | CSI 300 | -4.02% | 44.9% | -53.5% | -61.7% |
Hongkong Hang Seng | HSI | -6.88% | 34.9% | -63.8% | -68.1% |
India NIFTY 50 | INDA | -0.97% | 48.9% | -56.2% | -58.4% |
Brasil Bovespa | EWZ | -5.41% | 39.6% | -63.5% | -49.6% |
DYN vs. Sectors DYN is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | -3.54% | 47.5% | -60.5% | -76.4% |
Consumer Discretionary | XLY | -4.28% | 47.6% | -52.1% | -70.1% |
Consumer Staples | XLP | -2.99% | 49.1% | -61.2% | -63.6% |
Energy | XLE | -4.34% | 51.1% | -48.3% | -46.3% |
Financial | XLF | -3.99% | 45.6% | -60.2% | -77.6% |
Health Care | XLV | 0.43% | 55.5% | -49.1% | -50.1% |
Industrial | XLI | -4.93% | 43.8% | -55.3% | -66.0% |
Materials | XLB | -3.35% | 46.4% | -50.2% | -50.0% |
Real Estate | XLRE | -3.03% | 45.0% | -56.7% | -69.5% |
Technology | XLK | -4.25% | 44.4% | -52.0% | -63.0% |
Utilities | XLU | -4.40% | 45.5% | -62.1% | -71.9% |
Aerospace & Defense | XAR | -3.87% | 41.8% | -63.6% | -81.2% |
Biotech | XBI | 4.72% | 49.1% | -33.2% | -42.0% |
Homebuilder | XHB | -2.92% | 48.1% | -40.7% | -46.3% |
Retail | XRT | -3.51% | 47.5% | -48.0% | -51.7% |